Connection

Elizabeth Hill to Biomarkers, Tumor

This is a "connection" page, showing publications Elizabeth Hill has written about Biomarkers, Tumor.
Connection Strength

0.328
  1. Use of Biomarkers to Guide Decisions on Systemic Therapy for Women With Metastatic Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol. 2015 Aug 20; 33(24):2695-704.
    View in: PubMed
    Score: 0.096
  2. Discrimination of normal and esophageal cancer plasma proteomes by MALDI-TOF mass spectrometry. Dig Dis Sci. 2015 Jun; 60(6):1645-54.
    View in: PubMed
    Score: 0.093
  3. Plasma sphingolipids and lung cancer: a population-based, nested case-control study. Cancer Epidemiol Biomarkers Prev. 2013 Aug; 22(8):1374-82.
    View in: PubMed
    Score: 0.083
  4. Immune Responses Vary in Preinvasive Colorectal Lesions by Tumor Location and Histology. Cancer Prev Res (Phila). 2021 09; 14(9):885-892.
    View in: PubMed
    Score: 0.036
  5. Overexpression of RNA-binding protein CELF1 prevents apoptosis and destabilizes pro-apoptotic mRNAs in oral cancer cells. RNA Biol. 2013 Feb; 10(2):277-86.
    View in: PubMed
    Score: 0.020
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.